Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: results from the SURE Canada multicentre, prospective, observational study
Sidney Barritt IV, MD, director of hepatology at University of North Carolina School of Medicine in Chapel Hill, North Carolina, by improving risk factors that can affect liver health
We also provide ongoing guidance, monitoring, and support to help you achieve the best possible resultssafely and effectively
It is not intended to diagnose, treat, cure, or prevent any disease and should not be relied upon as a medical advice
For example, people with MS might fear worsening cognitive function as a result of the dual effects of MS and ageing
As always, follow any specific instructions from your healthcare provider